BBI-355
Product Specifications
CAS Number
2871056-82-3
SKU
C02004-5mg
Target
Chk
Applications
Cell Cycle
Additionnal Information
BBI-355 is an oral, potent, and selective small molecule inhibitor of CHK1 with an IC50 of 0.3 nM. It demonstrates significant anti-tumor activity as a single agent and in combination with targeted therapies in multiple ecDNA+ oncogene amplified tumor models.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
PB9786-Fluoro647 100 µg/Vial
Anti-LAR/PTPRF Antibody Picoband® Fluoro647 Conjugated
Sign In for Pricing
View Details 
MBS7084772-01 0.05 mg (E-Coli)
Recombinant Pongo abelii UPF0414 transmembrane protein C20orf30 homolog
Sign In for Pricing
View Details MBS7084772-02 0.05 mg (Yeast)
Recombinant Pongo abelii UPF0414 transmembrane protein C20orf30 homolog
Sign In for Pricing
View Details MBS7084772-03 0.2 mg (E-Coli)
Recombinant Pongo abelii UPF0414 transmembrane protein C20orf30 homolog
Sign In for Pricing
View Details MBS7084772-04 0.5 mg (E-Coli)
Recombinant Pongo abelii UPF0414 transmembrane protein C20orf30 homolog
Sign In for Pricing
View Details